Delavirdine

From WikiMD.org
Jump to navigation Jump to search

Delavirdine

Delavirdine (pronounced: /ˌdɛləˈvɪərdaɪn/) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV infection. It is marketed under the trade name Rescriptor.

Etymology

The name "Delavirdine" is derived from the chemical name 2',3'-dideoxy-3'-hydroxymethyl-4,6-dichloro-5-fluoropyrimidine. The prefix "Dela-" is a contraction of "dideoxy", and "-virdine" is a common suffix for non-nucleoside reverse transcriptase inhibitors.

Usage

Delavirdine is used in combination with other antiretroviral agents for the treatment of HIV-1 infection. It works by inhibiting the reverse transcriptase enzyme, thereby preventing the virus from multiplying in the body.

Related Terms

Side Effects

Common side effects of Delavirdine include skin rash, fatigue, headache, and nausea. Severe side effects may include liver damage and severe skin reactions.

Contraindications

Delavirdine should not be used in patients with severe liver disease or in combination with certain other medications due to the risk of drug interactions.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski